Generali Asset Management’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.89M Sell
34,097
-21,440
-39% -$1.72M 0.05% 252
2026
Q1
$4.65M Buy
55,537
+14,318
+35% +$1.08M 0.1% 195
2025
Q4
$2.76M Sell
41,219
-10,494
-20% -$678K 0.06% 252
2025
Q3
$3.5M Buy
51,713
+25,499
+97% +$1.85M 0.07% 220
2025
Q2
$1.95M Sell
26,214
-299
-1% -$19.9K 0.04% 315
2025
Q1
$1.67M Sell
26,513
-2,610
-9% -$161K 0.04% 336
2024
Q4
$1.66M Buy
+29,123
New +$1.72M 0.04% 324

Other funds holding CTVA

Generali Asset Management's CTVA Position: Q2 2026 in Review

Generali Asset Management reduced its Corteva (CTVA) stake by 39% in Q2 2026, selling an estimated $1.72M and leaving 34,097 shares worth $2.89M. The position accounts for 0.05% of the portfolio, ranked #252.

Generali Asset Management first reported a position in CTVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.65M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Generali Asset Management held 34,097 shares of Corteva worth $2.89M as of Q2 2026.
  • Generali Asset Management sold 21,440 Corteva shares in Q2 2026, an estimated $1.72M.
  • Corteva made up 0.05% of Generali Asset Management's portfolio in Q2 2026, its #252 holding.
  • Generali Asset Management first reported a position in Corteva in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Corteva position peaked at $4.65M in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.